Skip to main content

Advertisement

SpringerLink
Log in

Ipriflavone: Background

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nogradi M (1993) The ipriflavone story (1969–1993). Kem Kozl 77:55–58

    CAS  Google Scholar 

  2. Clarkson TB, Anthony MS, Hughes CL Jr (1995) Estrogenic soybean isoflavones and chronic disease. Risks and benefits. Trends Endocrinol Met 6:11–16

    Article  CAS  Google Scholar 

  3. Reginster JY (1993) Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis. Bone Miner 23:223–232

    Article  PubMed  CAS  Google Scholar 

  4. Anonymous (1994) Ipriflavone. Phase III Drug Prof 4(3): 10–15

  5. Orimo H (1990) Effects of ipriflavone in involutional osteoporosis. In: C. Christiansen and K. Overgaard (eds) Osteoporosis 1990, Osteopress ApS, Aalborg, Denmark 3:2156–2158

    Google Scholar 

  6. Szocsik K, Bart M, Bossany A, Nagy K (1990) Ipriflavone in the prevention of postmenopausal osteoporosis. In: Christiansen C, Overgaard K (eds) Osteoporosis 1990. Osteopress ApS, Aalborg, Denmark, pp 2164–2167

    Google Scholar 

  7. Agnusdei D, Camporeale A, Zacchei F, Gennari C, Baroni MC, Costi D, Biondi M, Passeri M, Ciacca A, Sbrenna C, Falsettini E, Ventura A (1992) Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr Ther Res 51:82–91

    Google Scholar 

  8. Gambacciani M, Spinetti A, Piaggesi L, Cappagli B, Taponeco F, Manetti P, Weiss C, Teti GC, La Commare P, Facchini V (1994) Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormonereleasing hormone agonists. Bone Miner 26:19–26

    Article  PubMed  CAS  Google Scholar 

  9. Kovacs A (1994) Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis. Agents Actions 41: 86–87

    Article  PubMed  CAS  Google Scholar 

  10. Maugeri D, Panebianco P, Russo MS, Motta M, Tropea S, Motta L, Garozzo C, Lomeo E, Sangiorgi GB, Scuderi G, Carozzo M, Cantatore FP, Perpignano G, Ferraraccio A, Ennas F (1994) Ipriflavone treatment of senile osteoporosis: results of a multicenter, double-blind clinical trial of 2 years. Arch Gerontol Geriatr 19:253–263

    Article  PubMed  CAS  Google Scholar 

  11. Valente M, Bufalino L, Castiglione GN, D’Angelo R, Mancuso A, Galoppi P, Zichella L (1994) Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 54:377–380

    Article  PubMed  CAS  Google Scholar 

  12. Passeri M, Biondi M, Costi D, Dall’Aglio E, Pedrazzoni M, Bufalino L, Castiglione GN, Abate G (1995) Effects of 2-year therapy with ipriflavone in elderly women with established osteoporosis. Ital J Mineral Electrolyte Metab 9:137–144

    CAS  Google Scholar 

  13. Melis GB, Paoletti AM, Cagnacci A (1996) Ipriflavone prevents bone loss in postmenopausal women. Menopause 3:27–32

    Google Scholar 

  14. Yamazaki I (1986) Effects of ipriflavone on the response of uterus and thyroid to estrogen. Life Sci 38:757–764

    Article  PubMed  CAS  Google Scholar 

  15. Melis GB, Paoletti AM, Cagnacci A, Bufalino L, Spinetti A, Gambacciani M, Fioretti P (1992) Lack of any estrogenic effect of ipriflavone in postmenopausal women. J Endocrinol Invest 15:755–761

    PubMed  CAS  Google Scholar 

  16. Cecchini MG, Fleisch H, Mühlbauer RC (1996) Ipriflavone inhibits bone resorption in rats: effect of experimental conditions (abstract). ASBMR Annual Meeting, Seattle, Washington State, USA, 7–11 September

Download references

Author information

Authors and Affiliations

  1. Internal Medicine and Medical Pathology Institute, University of Siena, Italy

    C. Gennari

Authors
  1. C. Gennari
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gennari, C. Ipriflavone: Background. Calcif Tissue Int 61 (Suppl 1), S3–S4 (1997). https://doi.org/10.1007/s002239900375

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900375

Keywords

Search

Navigation